WallStSmart

CryoCell International Inc (CCEL)vsUniversal Health Services Inc (UHS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 58861% more annual revenue ($18.35B vs $31.13M). UHS leads profitability with a 8.0% profit margin vs -6.3%. CCEL appears more attractively valued with a PEG of 1.34. UHS earns a higher WallStSmart Score of 62/100 (C+).

CCEL

Hold

47

out of 100

Grade: D+

Growth: 6.0Profit: 5.0Value: 7.0Quality: 5.5
Piotroski: 6/9Altman Z: -0.53

UHS

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 6.0Value: 6.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCELUndervalued (+33.5%)

Margin of Safety

+33.5%

Fair Value

$5.02

Current Price

$4.15

$0.87 discount

UndervaluedFair: $5.02Overvalued
UHSSignificantly Overvalued (-19.6%)

Margin of Safety

-19.6%

Fair Value

$193.34

Current Price

$179.43

$13.91 premium

UndervaluedFair: $193.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEL3 strengths · Avg: 10.0/10
Return on EquityProfitability
129.2%10/10

Every $100 of equity generates 129 in profit

EPS GrowthGrowth
75.1%10/10

Earnings expanding 75.1% YoY

Debt/EquityHealth
-0.0410/10

Conservative balance sheet, low leverage

UHS2 strengths · Avg: 10.0/10
P/E RatioValuation
8.2x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Areas to Watch

CCEL4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$39.10M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.6%3/10

Operating margin of 0.6%

Altman Z-ScoreHealth
-0.532/10

Distress zone — elevated risk

UHS2 concerns · Avg: 2.5/10
Profit MarginProfitability
8.0%3/10

8.0% margin — thin

EPS GrowthGrowth
-10.9%2/10

Earnings declined 10.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEL

The strongest argument for CCEL centers on Return on Equity, EPS Growth, Debt/Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Price/Book. PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bear Case : CCEL

The primary concerns for CCEL are Revenue Growth, Market Cap, Operating Margin.

Bear Case : UHS

The primary concerns for UHS are Profit Margin, EPS Growth.

Key Dynamics to Monitor

CCEL profiles as a turnaround stock while UHS is a value play — different risk/reward profiles.

UHS carries more volatility with a beta of 1.11 — expect wider price swings.

UHS is growing revenue faster at 5.3% — sustainability is the question.

UHS generates stronger free cash flow (422M), providing more financial flexibility.

Bottom Line

UHS scores higher overall (62/100 vs 47/100). CCEL offers better value entry with a 33.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CryoCell International Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?